Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of pembrolizumab plus paclitaxel in refractory small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer [Phase 2]
Phase 2 trial comparing etoposide plus lobaplatin vs etoposide plus cisplatin in limited small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing irinotecan plus lobaplatin vs irinotecan in second-line treatment of small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer [Phase 3]
A Phase 3 trial comparing nivolumab to chemotherapy in relapsed small-cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update examining the combination of anlotinib with sintilimab as second-line treatment or beyond for small cell lung cancer i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Pazopanib Maintenance for SCLC [Phase 2]
Phase 2 trial update on pazopanib maintenance therapy for small cell lung cancer (SCLC) completed.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC [Phase 2]
Phase 2 clinical trial evaluating chemoradiotherapy with or without sintilimab in limited-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC [Phase 2]
Phase 2 trial evaluating lobaplatin/etoposide with or without anlotinib maintenance in extensive-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing amrubicin with or without cisplatin to etoposide-cisplatin for extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy [Phase 3]
Phase 3 trial update for AMR PH GL 2007 CL001 in small cell lung cancer after failure of first-line chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy [Phase 2]
Phase 2 clinical trial evaluating amrubicin in patients with small cell lung cancer refractory or progressing after prior therapy has comple…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer [Phase 2]
Phase 2 trial update for rovalpituzumab tesirine in third-line and later Delta-like protein 3-expressing small cell lung cancer; results pos…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy [Phase 3]
Phase 3 trial evaluating nivolumab alone or with ipilimumab versus placebo in extensive-stage small cell lung cancer after platinum therapy …
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Appatinib in combination with S-1 for small cell lung cancer is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ipilimumab and nivolumab with thoracic radiotherapy for extensive-stage small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma [Phase 2]
Phase 2 trial evaluating NGR-hTNF in combination with doxorubicin in metastatic small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for etirinotecan pegol in refractory brain metastases, extensive-stage small cell lung cancer, recurrent NSCLC, metasta…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating pegylated irinotecan NKTR-102 in relapsed small cell lung cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer [Phase 3]
Phase 3 trial investigating anlotinib hydrochloride capsule in small cell lung cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of sintilimab (a PD-1 inhibitor) in combination with metformin for small-cell lung can…
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 3]
Phase 3 trial evaluating carboplatin/etoposide with or without atezolizumab in untreated extensive-stage small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) [Phase 2]
A phase 2 clinical trial update for anlotinib in small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy [Phase 1, Phase 2]
A Phase 1b/2 study of tarextumab (OMP-59R5) in combination with etoposide and platinum therapy in Stage IV small cell lung cancer was termin…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating temozolomide for preventing brain metastases in small cell lung cancer is reported as ongoing with un…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride [Phase 4]
Phase 4 clinical trial investigating first-line treatment of small cell lung cancer with anlotinib hydrochloride.